Related Experiment Video
Updated: May 9, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
Suppression of inflammatory gene expression in T cells by Porphyromonas gingivalis is mediated by targeting MAPK
Hazem Khalaf1, Isak Demirel, Torbjörn Bengtsson
1Division of Clinical Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden
Abstract:
There is increasing awareness of the effects of Porphyromonas gingivalis on host immune responses. Degradation of cytokines and chemokines by cysteine proteinases has previously been reported. However, the precise mechanisms by which P. gingivalis is able to alter intracellular signaling, and thus proliferation and inflammation, have not been described. We have previously reported suppression of activator protein-1 (AP-1) and degradation of IL-2 by proteinases from P. gingivalis. In the present study, we have analyzed the effects of P. gingivalis on Jurkat T-cell signal transduction and subsequent IL-2 and CXCL8 expression. We found that CXCL8, but not IL-2, gene expression levels were significantly suppressed by viable P. gingivalis. Analysis of intracellular signaling revealed an inhibitory effect of P. gingivalis on c-Jun and c-Fos, but not NFκB (p50 and p65), NFAT or STAT5 expression. This inhibitory effect was not due to suppression of mitogen-activated protein kinase (MAPK) (p38, erk and JNK) gene expression, but was rather due to prevention of protein kinase C (PKC) and p38 phosphorylation, as demonstrated by western blot analysis. Furthermore, SOCS1 and SOCS3 expression levels decreased following treatment of Jurkat T cells with viable P. gingivalis. The results indicate that P. gingivalis is able to suppress inflammatory gene expression by targeting the activity of MAPK pathways in T cells, which was confirmed by using specific inhibitors of NF-κB, PKC, ERK, p38 and JNK.
Insights
Porphyromonas gingivalis suppresses inflammatory gene expression by inhibiting T-cell signaling pathways. This bacterium targets mitogen-activated protein kinase (MAPK) pathways, affecting immune responses.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Porphyromonas gingivalis is known to impact host immune responses.
- Previous research indicated degradation of cytokines and chemokines by bacterial cysteine proteinases.
- Mechanisms of P. gingivalis in altering intracellular signaling, proliferation, and inflammation remain unclear.
Purpose of the Study:
- To investigate the effects of P. gingivalis on Jurkat T-cell signal transduction.
- To analyze the impact on Interleukin-2 (IL-2) and CXCL8 gene expression.
- To elucidate the specific intracellular signaling pathways affected by P. gingivalis.
Main Methods:
- Analysis of gene expression levels for IL-2 and CXCL8 in Jurkat T-cells treated with P. gingivalis.
- Western blot analysis to assess the phosphorylation status of key signaling proteins, including protein kinase C (PKC) and p38.
- Examination of intracellular signaling pathways such as activator protein-1 (AP-1), NFκB, NFAT, STAT5, and mitogen-activated protein kinases (MAPKs).
Main Results:
- Viable P. gingivalis significantly suppressed CXCL8 gene expression, but not IL-2.
- P. gingivalis inhibited the expression of c-Jun and c-Fos, key components of AP-1, without affecting NFκB, NFAT, or STAT5.
- The bacterium prevented phosphorylation of PKC and p38, crucial steps in MAPK signaling, and decreased SOCS1 and SOCS3 expression.
Conclusions:
- P. gingivalis suppresses inflammatory gene expression by targeting MAPK pathways in T cells.
- The bacterium's mechanism involves inhibiting PKC and p38 phosphorylation, thereby modulating T-cell responses.
- These findings provide insight into how P. gingivalis manipulates host immune signaling.
Related Concept Videos
The Oral Microbiota
Gene Regulation in Microbial Communities: Quorum Sensing
Gastritis II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
